RELATIONSHIP BETWEEN METABOLIC SYNDROME AND INFLAMMATION IN PERITONEAL DIALYSIS PATIENTS
dc.authorid | OZTURK, YASIN/0000-0003-2634-2677 | |
dc.contributor.author | Borazan, A. | |
dc.contributor.author | Ucar, E. | |
dc.contributor.author | Gursu, M. | |
dc.contributor.author | Emir, I. | |
dc.contributor.author | Ozturk, Y. | |
dc.date.accessioned | 2024-09-18T20:54:11Z | |
dc.date.available | 2024-09-18T20:54:11Z | |
dc.date.issued | 2012 | |
dc.department | Hatay Mustafa Kemal Üniversitesi | en_US |
dc.description.abstract | We aimed to investigate the relationship between inflammation and metabolic syndrome as defined by the National Cholesterol Education Program Adults Treatment Panel III (NCEP-ATP III) diagnostic criteria in peritoneal dialysis patients. Ninety-four patients treated with peritoneal dialysis were included in the study. Patients' age, sex, weight, waist circumference, arterial blood pressure, fasting blood glucose, total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides, C-reactive protein, albumin, uric acid and fibrinogen levels were recorded. Fourty-one patients diagnosed with metabolic syndrome and 53 peritoneal dialysis patients without metabolic syndrome were identified. In the metabolic syndrome group mean decrease in serum albumin and mean increase in C-reactive protein and fibrinogen was significantly different from the other group (p < 0.05, p < 0.05, p < 0.05, respectively). When gender, diabetes mellitus, and hypertension status were evaluated, the difference was not significant (p > 0.05). Peritoneal dialysis patients with metabolic syndrome should also be assessed for inflammation. | en_US |
dc.identifier.doi | 10.1177/1721727X1201000205 | |
dc.identifier.endpage | 207 | en_US |
dc.identifier.issn | 1721-727X | |
dc.identifier.issn | 2058-7392 | |
dc.identifier.issue | 2 | en_US |
dc.identifier.scopus | 2-s2.0-84867217123 | en_US |
dc.identifier.scopusquality | Q4 | en_US |
dc.identifier.startpage | 203 | en_US |
dc.identifier.uri | https://doi.org/10.1177/1721727X1201000205 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12483/11649 | |
dc.identifier.volume | 10 | en_US |
dc.identifier.wos | WOS:000308771600005 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | en | en_US |
dc.publisher | Sage Publications Inc | en_US |
dc.relation.ispartof | European Journal of Inflammation | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | peritoneal dialysis | en_US |
dc.subject | metabolic syndrome | en_US |
dc.subject | C-reactive proteine | en_US |
dc.subject | albumin | en_US |
dc.subject | uric acid | en_US |
dc.subject | fibrinogen | en_US |
dc.title | RELATIONSHIP BETWEEN METABOLIC SYNDROME AND INFLAMMATION IN PERITONEAL DIALYSIS PATIENTS | en_US |
dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1